Ticlopidine-, Clopidogrel-, and Prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SOAR)
- Creators
- Jacob, Sony
- Dunn, Brianne L.
- Qureshi, Zaina, 1982-
- Bandarenko, Nicholas
- Kwaan, Hau C
- Pandey, Dilip K.
- McKoy, June M
- Barnato, Sara E.
- Winters, Jeffrey L.
- Cursio, John F.
- Weiss, Ivy M
- Raife, Thomas J.
- Carey, Patricia M.
- Sarode, Ravindra
- Kiss, Joseph E.
- Danielson, Constance
- Ortel, Thomas L. (Thomas Lee), 1957-
- Clark, William F.
- Rock, Gail
- Matsumoto, Masanori, 1935-
- Fujimura, Yoshihiro
- Zheng, X. Long
- Chen, Hao
- Chen, Fei
- Armstrong, John M.
- Raisch, Dennis W.
- Bennet, Charles L.
Abstract
Thienopyridine derivatives (ticlopidine, clopidogrel, and prasugrel) are the primary antiplatelet agents. Thrombotic thrombocytopenic purpura (TTP) is a rare drug-associated syndrome, with the thienopyridines being the most common drugs implicated in this syndrome. We reviewed 20 years of information on clinical, epidemiologic, and laboratory findings for thienopyridine-associated TTP. Four, 11, and 11 cases of thienopyridine- associated TTP were reported in the first year of marketing of ticlopidine (1989), clopidogrel (1998), and prasugrel (2010), respectively. As of 2011, the FDA received reports of 97 ticlopidine-, 197 clopidogrel-, and 14 prasugrel-associated TTP cases. Severe deficiency of ADAMTS-13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif member 13) was present in 80% and antibodies to 100% of these TTP patients on ticlopidine, 0% of the patients with clopidogrel-associated TTP (p < 0.05), and an unknown percentage of patients with prasugrel-associated TTP. TTP is associated with use of each of the three thienopyridines, although the mechanistic pathways may differ.
Other
original_citation: Jacob, S., Dunn, B. L., Qureshi, Z. P., Bandarenko, N., Kwaan, H. C., Pandey, D. K., . . . Bennett, C. L. (2012). Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost, 38(8), 845-853. doi:10.1055/s-0032-1328894
Files
Name | Size | Download all |
---|---|---|
md5:ff83d873b31721e46c319ddfbd6c7bcb
|
9.0 MB | Preview Download |
Additional details
- PMID
- 23111862
- ARK
- ark:/c8131/g3bk5p
- Created
-
2012-10-30When the item was originally created.